Medtronic's recent regulatory approvals should bode well for non-GAAP EPS growth in the coming years. Read why I am ...

Medtronic offers a compelling long-term investment opportunity with solid revenue and earnings growth, driven by innovation ...

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor ...

The message that Ainnova’s CEO, Vinicio Vargas, continues to convey to audiences around the world is that this accessible, fast, and scalable solution is designed to support early intervention and ...

1,414 patients were randomized, with 730 receiving TAVR with either a Medtronic Evolut R, PRO, or CoreValveTM and 684 undergoing surgery. Spectral AI, Inc. (NASDAQ: MDAI) , a leading developer of the ...

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

KIMS-Sunshine Hospital has partnered with Medtronic, a medical technology player, to establish a specialised center for renal denervation therapy. Through this initiative, Medtronic will support ...

Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of measuring the ...

Medtronic’s Evolut outcomes similar to surgery Patients who received Medtronic’s Evolut transcatheter aortic valve replacement had rates of death or disabling stroke at five years that were comparable ...

Medtronic plc, a global leader in healthcare technology, announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut transcatheter aortic ...